Products - Head and neck cancers | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Dusquetide for treating oral mucositis during chemoradiation for head and neck cancer [ID3830]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer [ID6406]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Pembrolizumab for neoadjuvant and with radiotherapy for adjuvant treatment of newly diagnosed resectable locally advanced squamous cell head and neck cancer [ID6477]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC